![]() |
|
Clinical
Research Trials
|
|
|
MD-CHF - Principal Investigator: Michael Klein, MD The use of open-labeled Toprol-XL in heart failure patients. Toprol-XL 25, 50, 100, 200 mg open-label followed by double- blind up-titration to target dose. Enrollment criteria are LV ejection fraction </= 40%. NYHA class II-III. Research Coordinator:
Nancy Zuech Lim, RN (617) 638-8060 Please click on a research project for more information.
|
|
| ||
|
|
Last
modified:
February 4, 2004
Contact: Page Author |
|